#Switzerland #medical technology #Geneva #Neurotherapeutics #MindMaze Therapeutics

MindMaze Therapeutics to Showcase Innovations at Major Conferences

MindMaze Therapeutics Holding SA is gearing up to present at a series of highly anticipated investor and industry conferences this fall. As a frontrunner in scalable precision neurotherapeutics, MindMaze is eager to demonstrate how its groundbreaking solutions can transform neurorehabilitation.

Key Conferences Ahead

MindMaze will participate in several notable conferences across both the United States and Europe:

• - Baader Investment Conference in Munich, Germany on September 21, 2026. This event offers an opportunity for investors to gain insights into MindMaze's strategic vision and innovations. The company's management will be available for one-on-one meetings, helping foster strong relationships with potential investors.
• - Global Markets Forum in New York City on October 7, 2026. Here, attendees can expect a comprehensive overview of the latest developments in neurotechnology, and how MindMaze is positioned to lead the charge.

Additionally, MindMaze plans to showcase its innovations at several industry conferences:

• - The American Medical Rehabilitation Providers Association (AMRPA) Educational Conference from September 27–30, 2026 in Austin, TX.
• - The American Congress of Rehabilitation Medicine (ACRM) Annual Fall Conference in Washington, DC from October 13–15, 2026.
• - The American Academy of Physical Medicine and Rehabilitation (AAPMR) 2026 Annual Assembly in Orlando, FL from November 11–14, 2026.
• - The HLTH USA 2026 conference in Las Vegas, NV on November 17, 2026.

At these events, MindMaze will present a plethora of real-world evidence showcasing the effectiveness of its neurotechnology solutions. This is pivotal in demonstrating how these therapies can revolutionize the delivery of neurorehabilitation across the healthcare continuum, from hospital settings to outpatient care and even home therapy solutions.

Advancing Neurorestorative Medicine

MindMaze Therapeutics is committed to redefining the recovery journey for patients suffering from neurological conditions. Utilizing cutting-edge software, proprietary sensors, and advanced AI-driven data analytics, the company offers a continuous spectrum of care that addresses the critical shortage of specialized clinicians worldwide. Their innovative products are designed not only to aid in rehabilitation but also to ensure affordability and ease of access for patients dealing with conditions such as stroke and Parkinson's disease.

The company prides itself on a robust research and development pipeline, supported by extensive clinical validation of its products. This ensures that MindMaze remains at the forefront of neurorestorative medicine, paving the way for more effective treatment solutions in the future.

For more information regarding the conferences and to access presentation materials and replays, you can visit MindMaze Therapeutics' official website.

As these conferences draw closer, anticipation builds for how MindMaze Therapeutics will showcase its contributions to neurorehabilitation and engage with the investment community, reinforcing its position as a leader in the healthcare sector.